Review our resources for client conversations.
Help clients understand how our distinct business model funds innovative medical research.
We're always looking for exceptional team members.
By Mike Liss - April 17, 2018
It’s been a rough period for value. With the value index underperforming the growth index in large cap stocks by 2,000 basis points over the past year, I would say this is likely the most we’ve been out of favor since I started in 1998.
But the value strategy is still where my passion lies, and I see plenty of opportunity on the horizon. Right now, my focus is on energy. Healthcare is also on my radar, and specifically pharmaceuticals and medical technology. In this quarter’s outlook, I focus on that and why bottom-up investors still pay attention to the top down.
We believe focusing on companies’ potential for long-term, sustainable earnings growth is key to helping endure the economic downturn fueled by COVID-19.
The market’s worst days don’t have to be your portfolio’s worst days. Here are some of the benefits of keeping an eye on quality.
What’s our strategy for finding high-quality overlooked companies? Our Equity Income team shares their insights and expert perspectives.
“Unprecedented” sounds cliché, but it’s still the best way to describe the current market and economic situation. What does that mean for value investing?
It’s too early for value investors to declare victory, but last quarter’s value rebound has Sr. PM Mike Liss optimistic about these opportunities.
Tariffs. Rising rates. Geopolitical turmoil. None of this deters Sr. Portfolio Manager Mike Liss on his mission to turn high-quality companies underperforming into shareholder return. See which industries are on his radar this quarter.
April 17, 2018
The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments' portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.